HOME >> MEDICINE >> NEWS
Statins show early promise for treating multiple sclerosis

Results of a preliminary study in this week's issue of THE LANCET suggest that statins (cholesterol-lowering drugs) could have potential in the treatment of multiple sclerosis (MS).

Drug treatments for MS are expensive and only partially effective. Recent knowledge that statins promote an anti-inflammatory response from the immune system suggest a potential in the treatment of MS.

Inderjit Singh from the Medical University of South Carolina, USA, and colleagues report how 30 people with MS given 80 mg simvastatin daily for 6 months had a 44% reduction in the proportion of brain lesions after three months of treatment compared with lesions identified before treatment initiation.

Dr Singh comments: "These findings suggest that an 80 mg daily dose of oral simvastatin over a 6 month period could inhibit the inflammatory components of multiple sclerosis that lead to neurological disabilityOur results, combined with the published work on the immunological effects of statins lend support to the case for randomised controlled clinical trials to establish the safety and efficacy of statins in the treatment of relapsing-remitting multiple sclerosis".

In an accompanying Commentary (p 1570), Chris Polman from VU Medical Centre, Amsterdam, Netherlands, concludes: "[this] study is a big step forward because it is the first to provide some evidence of an effect with a statin in multiple sclerosis-but it is only an initial step. Additional data are required to more precisely determine the clinical effects of statins, to explore the optimum dose, the therapeutic window, and the differential potency of statins, and to evaluate whether combination therapy might be more effective than monotherapy. Physicians, scientists, drug companies, and regulatory agencies should now work together to design and do randomised studies that have adequate power to address these and other important issues. It is the joint responsibility of all involved to ensure that some
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
13-May-2004


Page: 1 2

Related medicine news :

1. Statins effective in long term, Nordic study suggests
2. Statins and aspirin may protect against severe vision loss in elderly
3. Statins could reduce stroke risk by a third
4. Statins may inhibit calcium growth on aortic valve in the elderly
5. International Study Finds Statins Raise Good Cholesterol, Wake Forest Physician Reports
6. New marker for early diagnosis of kidney failure identified
7. English-speaking Hispanic youth more likely to have sex early
8. Inpatient smoking cessation counseling is associated with early differences in mortality
9. Study finds no reason for expectant mothers to shy away from early epidurals
10. No increase in C-sections when epidural analgesia given early in labor
11. Radiologists offer non-surgical treatment for early-stage liver cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 04, 2020 , ... Total Spectrum, a ... Disorder (ASD) in Wisconsin, is delighted to announce the grand opening of their ... their newest center, Total Spectrum now proudly serves ten different locations across the ...
(Date:8/5/2020)... ... ... Today, Power to Decide’s One Key Question was recognized by ... Best Practice Award. The One Key Question program is a transformative tool that starts ... a child. One Key Question is used by thousands of health care, social service ...
(Date:8/3/2020)... , ... August 03, 2020 , ... ... the launch of its newest product, CoverageCoach. The site provides a simple and ... purchase insurance products. The company sees CoverageCoach as an important expansion for the ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... the first patients with first-line advanced pancreatic cancer in a phase 2 study ... of 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). 9-ING-41 is Actuate’s proprietary small molecule glycogen synthase ...
(Date:7/31/2020)... ... July 31, 2020 , ... ... new patients to The Dental Studio of Midland for groundbreaking laser dentistry ... a result, these patients are able to experience the many advantages of laser ...
Breaking Medicine News(10 mins):
(Date:8/3/2020)... ... August 03, 2020 , ... Hide-a-Mask, a hat with ... over $36,000 in less than three weeks since launch. Hide-a-Mask is ideal for anyone ... for our early backers who, like us, believe having a mask at your fingertips ...
(Date:7/31/2020)... Texas (PRWEB) , ... July 31, 2020 , ... As ... Studios has been providing residents of Missouri City, TX, with a wide range ... 6, Suite 300, is a state-of-the-art dental facility that is not far from the ...
(Date:7/31/2020)... ... ... In an informal poll of 150 fans, conducted by long-time Twins fan Charles ... and Paul” logo that is more racially and culturally sensitive and inclusive. The original ... rights movement in the United States. The Minnesota Twins have never updated their logo, ...
Breaking Medicine Technology:
Cached News: